352 related articles for article (PubMed ID: 26364685)
21. Stabilization of rinderpest vaccine by modification of the lyophilization process.
House JA; Mariner JC
Dev Biol Stand; 1996; 87():235-44. PubMed ID: 8854023
[TBL] [Abstract][Full Text] [Related]
22. Recent advances and further challenges in lyophilization.
Kasper JC; Winter G; Friess W
Eur J Pharm Biopharm; 2013 Oct; 85(2):162-9. PubMed ID: 23751601
[TBL] [Abstract][Full Text] [Related]
23. Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review.
Geidobler R; Winter G
Eur J Pharm Biopharm; 2013 Oct; 85(2):214-22. PubMed ID: 23643793
[TBL] [Abstract][Full Text] [Related]
24. Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring.
De Beer TR; Allesø M; Goethals F; Coppens A; Heyden YV; De Diego HL; Rantanen J; Verpoort F; Vervaet C; Remon JP; Baeyens WR
Anal Chem; 2007 Nov; 79(21):7992-8003. PubMed ID: 17896825
[TBL] [Abstract][Full Text] [Related]
25. Effect of freezing rates and excipients on the infectivity of a live viral vaccine during lyophilization.
Zhai S; Hansen RK; Taylor R; Skepper JN; Sanches R; Slater NK
Biotechnol Prog; 2004; 20(4):1113-20. PubMed ID: 15296437
[TBL] [Abstract][Full Text] [Related]
26. Effect of Controlled Ice Nucleation on Stability of Lactate Dehydrogenase During Freeze-Drying.
Fang R; Tanaka K; Mudhivarthi V; Bogner RH; Pikal MJ
J Pharm Sci; 2018 Mar; 107(3):824-830. PubMed ID: 29074380
[TBL] [Abstract][Full Text] [Related]
27. Impact of Ice Morphology on Design Space of Pharmaceutical Freeze-Drying.
Goshima H; Do G; Nakagawa K
J Pharm Sci; 2016 Jun; 105(6):1920-1933. PubMed ID: 27238489
[TBL] [Abstract][Full Text] [Related]
28. Freeze drying optimization of polymeric nanoparticles for ocular flurbiprofen delivery: effect of protectant agents and critical process parameters on long-term stability.
Ramos Yacasi GR; Calpena Campmany AC; Egea Gras MA; Espina García M; García López ML
Drug Dev Ind Pharm; 2017 Apr; 43(4):637-651. PubMed ID: 28044462
[TBL] [Abstract][Full Text] [Related]
29. Freeze-Drying of Lactic Acid Bacteria: A Stepwise Approach for Developing a Freeze-Drying Protocol Based on Physical Properties.
Fonseca F; Girardeau A; Passot S
Methods Mol Biol; 2021; 2180():703-719. PubMed ID: 32797444
[TBL] [Abstract][Full Text] [Related]
30. Lyophilization process design space.
Patel SM; Pikal MJ
J Pharm Sci; 2013 Nov; 102(11):3883-7. PubMed ID: 23946165
[TBL] [Abstract][Full Text] [Related]
31. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
[TBL] [Abstract][Full Text] [Related]
32. Freeze drying of red blood cells: the use of directional freezing and a new radio frequency lyophilization device.
Arav A; Natan D
Biopreserv Biobank; 2012 Aug; 10(4):386-94. PubMed ID: 24849889
[TBL] [Abstract][Full Text] [Related]
33. Freeze-drying of nanosuspensions, 1: freezing rate versus formulation design as critical factors to preserve the original particle size distribution.
Beirowski J; Inghelbrecht S; Arien A; Gieseler H
J Pharm Sci; 2011 May; 100(5):1958-68. PubMed ID: 21374626
[TBL] [Abstract][Full Text] [Related]
34. Next generation drying technologies for pharmaceutical applications.
Walters RH; Bhatnagar B; Tchessalov S; Izutsu KI; Tsumoto K; Ohtake S
J Pharm Sci; 2014 Sep; 103(9):2673-2695. PubMed ID: 24916125
[TBL] [Abstract][Full Text] [Related]
35. The Impact of Formulation Composition and Process Settings of Traditional Batch Versus Continuous Freeze-Drying On Protein Aggregation.
Vanbillemont B; Carpenter JF; Probst C; De Beer T
J Pharm Sci; 2020 Nov; 109(11):3308-3318. PubMed ID: 32739274
[TBL] [Abstract][Full Text] [Related]
36. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine.
Burger JL; Cape SP; Braun CS; McAdams DH; Best JA; Bhagwat P; Pathak P; Rebits LG; Sievers RE
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):25-34. PubMed ID: 18518829
[TBL] [Abstract][Full Text] [Related]
37. Suppression of protein inactivation during freezing by minimizing pH changes using ionic cryoprotectants.
Krausková Ľ; Procházková J; Klašková M; Filipová L; Chaloupková R; Malý S; Damborský J; Heger D
Int J Pharm; 2016 Jul; 509(1-2):41-49. PubMed ID: 27224008
[TBL] [Abstract][Full Text] [Related]
38. The Importance of Understanding the Freezing Step and Its Impact on Freeze-Drying Process Performance.
Assegehegn G; Brito-de la Fuente E; Franco JM; Gallegos C
J Pharm Sci; 2019 Apr; 108(4):1378-1395. PubMed ID: 30529167
[TBL] [Abstract][Full Text] [Related]
39. Stability study perspective of the effect of freeze-drying using cryoprotectants on the structure of insulin loaded into PLGA nanoparticles.
Fonte P; Soares S; Sousa F; Costa A; Seabra V; Reis S; Sarmento B
Biomacromolecules; 2014 Oct; 15(10):3753-65. PubMed ID: 25180545
[TBL] [Abstract][Full Text] [Related]
40. Improved formulation and lyophilization cycle for rBCG vaccine.
Jin TH; Nguyen L; Qu T; Tsao E
Vaccine; 2011 Jun; 29(29-30):4848-52. PubMed ID: 21549782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
